While some of our multinational competitors have historically taken an approach of not broadly licensing their germplasm or trait inventions, Monsanto has chosen a much different path. We broadly license germplasm and our trait innovations so farmers can realize the benefits from these inventions through the brands they prefer to plant on their farm.
We believe Monsanto’s broad licensing approach has made a huge difference in the choices available to farmers. This approach has been an important step in putting farmers first in our business. The way we have licensed our inventions does not prevent seed companies from using and selling competitive traits. For example, a company licensing Genuity® Roundup Ready 2 Yield® soybeans may continue to sell and market first-generation Roundup Ready® soybeans and they may in-license and sell any other soybean trait. All seed companies, including us, need to produce seed based on farmers’ demand.
While our agreements do not permit us to discuss the specific terms of particular licenses, we can speak generally about them. Much of what is commonly said about our licenses is wrong, and we’d like to set the record straight.